|
WO2021030452A1
|
|
Permeation enhancers, compositions containing them, and methods of using the same
|
|
WO2021030451A1
|
|
Glycerol as a permeation enhancer and compositions containing the same
|
|
WO2020243536A1
|
|
Methods of otoprotection against platinum-based antineoplastic agents
|
|
WO2020163761A1
|
|
Myosin 15 promoters and uses thereof
|
|
WO2020163743A1
|
|
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
WO2020123713A1
|
|
Compositions and methods for the delivery of therapeutic agents across the round window membrane
|
|
WO2020077295A1
|
|
Aav1 vectors and uses thereof for treatment of otic indications
|
|
US10813947B1
|
|
Methods of otoprotection against platinum-based antineoplastic agents
|
|
AU2019257782A1
|
|
Myosin 15 promoters and uses thereof
|
|
US2020155705A1
|
|
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
EP3749309A1
|
|
Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent
|
